AutonomUS Medical Technologies

AutonomUS Medical Technologies

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.autonomus.ai/

Last Round

Series A

Jun 18, 2025

Total Funding Raised

$100,000

Momentum Score

50 /100

Company Overview

AutonomUS Medical Technologies is a medical robotics company developing an AI-enabled, ultrasound-guided handheld robotic device for minimally invasive interventional procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Defense Tech, Medical Imaging

Business Model

B2G

Customer Profile

Government Contracts, Usage-Based SaaS, Hardware Sales

AI Layer

Application

Keywords

handheld robotic deviceultrasound-guided roboticsmedical roboticsminimally invasive proceduresAI medical devicevascular accessrobotic needle guidancecentral line placementmedical imaging AIportable ultrasoundMedTechmilitary medical technologybattlefield medicinerazor and blade modeldisposable medical cartridgesfirst responder technologyFDA Breakthrough Device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AutonomUS Medical Technologies Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AutonomUS Medical Technologies Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJun 18, 2025
GrantMay 16, 2025
SeedMay 15, 2025
Early FundingMay 16, 2023

Key People

Founding team and executive leadership

Romeo Catracchia

Chief Executive Officer Board Member

Executive Team

AutonomUS Medical Technologies Investors

Notable investors and investment history

InvestorRounds
Engine VenturesEarly Funding, Series A, Seed
SBXiEarly Funding
MassVenturesSeries A, Grant
Pimlico Pond InvestmentsSeries A
PhiFund VenturesSeries A, Seed, Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2025

    Collaborates closely with MIT and Massachusetts General Hospital.

  • Jul 1, 2025

    Earned designation from the FDA for a new medical device.

AutonomUS Medical Technologies Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AutonomUS Medical Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AutonomUS Medical Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range16
Year Founded2022
Last FundingJun 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.